This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Calcimedica, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Rachel Leheny: Innovator in Acute Lung Injury Treatment
Introduction
Rachel Leheny is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of medical science, particularly in the treatment of acute lung injury and acute respiratory distress syndrome. Her innovative work has the potential to impact many lives by addressing critical health issues.
Latest Patents
Rachel Leheny holds a patent for "Methods and compositions for treating acute lung injury and acute respiratory distress syndrome." This patent includes compositions and methods related to the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), including viral pneumonia. The invention focuses on the pharmaceutical manipulation of calcium signaling to reduce pro-inflammatory cytokine releases that may lead to ALI and/or ARDS.
Career Highlights
Leheny is currently associated with Calcimedica, Inc., where she continues to develop her groundbreaking research. Her work is characterized by a commitment to improving patient outcomes through innovative medical solutions.
Collaborations
Rachel collaborates with notable colleagues, including Michael Dunn and Kenneth Stauderman, who contribute to her research efforts and enhance the impact of her inventions.
Conclusion
Rachel Leheny exemplifies the spirit of innovation in the medical field, with her patent addressing critical health challenges. Her contributions are paving the way for advancements in the treatment of acute lung injuries and respiratory conditions.